MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2026 International Congress

    Medical Management of Late-stage Parkinson’s Disease – a Cross-sectional, Multinational Survey

    C. Pallauf, C. Weck, C. Brandl, S. Lorenzl (Salzburg, Austria)

    Objective: To investigate disease characteristics and common drug treatment of late-stage Parkinsons’ disease (LSPD). Background: LSPD presents with disabling motor and non-motor symptoms, the latter…
  • 2026 International Congress

    Does Knowing More Mean Tolerating More? Satisfaction with Medication Information and Levodopa Dosage in Parkinson’s Disease

    M. da Silva, M. Tosin, L. Silveira-Moriyama (Campinas, Brazil)

    Objective: To characterize the correlation between satisfaction with medication-related information and daily levodopa dosage in Parkinson’s disease (PD) patients presenting with levodopa-related complaints. Background: Adequate…
  • 2026 International Congress

    Foslevodopa-Foscarbidopa Continuous Subcutaneous Infusion Leads to Long-Term Reduction in Dyskinesia in Parkinson’s Disease: Results from 5-Year Follow-Up

    N. Jeyakumar, P. Becker, M. Georgiades, D. Tsui, X. Chen, S. Bray, J. Qiu, S. Waller, L. Williams, S. Dal, T. Ong, A. Martin, H. Morales-Briceno, V. Fung (Sydney, Australia)

    Objective: To investigate the long-term impact of foslevodopa-foscarbidopa continuous subcutaneous infusion (CSCI) on dyskinesia in Parkinson’s disease (PD). Background: Foslevodopa-foscarbidopa CSCI is an emerging treatment…
  • 2026 International Congress

    Parkinsonism Induced By An Interpeduncular Cistern Epidermoid Cyst A Case Report And Literature Review

    M. Salas-Crisostomo, A. Calderon-Garciduenas, D. Lopez-Mena, H. Martinez-Hernandez (Mexico City, Mexico)

    Objective: To describe a patient with parkinsonism secondary to an interpeduncular cistern cyst causing midbrain compression, highlighting clinical features, structural and molecular imaging findings, and…
  • 2025 International Congress

    Computer Vision Quantification of Repeated Finger Tapping Demonstrates Aberrant Plasticity in Parkinson’s Disease

    D. Newbold, U. Kang (New York, USA)

    Objective: Test if symptoms of Parkinson's disease (PD) develop through aberrant plasticity. Background: Recent results in 6-hydroxydopamine-lesioned mice show that repeated performance of simple motor…
  • 2025 International Congress

    Mucuna pruriens for FOG in Parkinson’s disease, Do we have a solution for this trivial problem?

    M. Matta, N. Sawal, S. Singh, K. Verma, S. Sharma (Chandigarh, India)

    Objective: To study the effects of Mucuna Pruriens when administered via inhalation route,  to alleviated symptoms of Parkinson's disease most importantly freezing of gait. Background: Mucuna…
  • 2025 International Congress

    Mutations of the VPS13A gene in a patient with Early-Onset Parkinson’s Disease: A case report.

    H. Pacheco, V. Gómez, C. Sánchez, L. Núñez (Mexico, Mexico)

    Objective: To describe the case of a patient with early-onset Parkinson's Disease (PD) with variants of the VPS13A gene. Background: The vacuolar protein sorting 13A…
  • 2025 International Congress

    L-DOPA Induced Iron Accumulation in the Ventral Midbrain: The Roles of Sex and Iron Repletion

    R. Serpa, K. Palsa, E. Tufano, T. Helmuth, S. Mills-Huffnagle, M. Kant, J. Connor (Hershey, USA)

    Objective: This study aims to investigate the impact of L-3,4-dihydroxyphenylalanine (L-DOPA) on ventral midbrain (VMB) iron levels under iron deficiency (ID) and repletion (IR) conditions…
  • 2025 International Congress

    Unraveling the Intertwined Relationship of DBS, Parkinson’s Disease Subtype and LEDD: A Retrospective Study

    T. Mehta, V. Lavu, C. Hess, A. Ramirez-Zamora, M. Okun, J. Wong (Gainesville, USA)

    Objective: To assess the impact of deep brain stimulation (DBS) target and Parkinson’s disease (PD) motor subtype on the total levodopa equivalent daily dose (LEDD)…
  • 2025 International Congress

    VPS13C: a Modifier Gene causing Suboptimal Response to Levodopa in Early-Onset Parkinson’s Disease

    L. Malfer, C. Piat, O. Ross, Z. Niu, E. Benarroch, R. Savica (Jacksonville, USA)

    Objective: To describe a retrospective clinical study of four cases carrying heterozygous pathogenic variants in the VPS13C gene with a clinical diagnosis of Early-Onset Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 70
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley